Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 449.40
Bid: 448.80
Ask: 449.40
Change: 0.00 (0.00%)
Spread: 0.60 (0.134%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 449.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Aug 2015 10:00

RNS Number : 5057V
QinetiQ Group plc
10 August 2015
 



QinetiQ Group plc

 

10 August 2015

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR THEIR CONNECTED PERSONS

 

Vesting of Award under the QinetiQ Group plc 2012 Performance Share Plan

The Company announces that on 10 August 2015 the following Executive Director acquired Ordinary Shares of 1p each ('Shares'), as detailed in the table below, as a result of the vesting of part of an award granted on 9 August 2012 under the QinetiQ Group plc 2012 Performance Share Plan ('PSP'):

Director

Number of Shares acquired on vesting under the PSP Award on 10 August 2015

% of Issued Share Capital

David Mellors

65,860

0.01%

 

The balance of the 2012 PSP award granted to Mr Mellors did not meet the performance targets and has lapsed.

The PSP operates as follows:

Vesting of awards granted under the PSP occurs three years after the award date, subject to the achievement of the following performance conditions:

(i) 50% of an award is subject to an Earnings per Share target set over a three year performance period; and

(ii) 50% of an award is subject to Total Shareholder Return measured over a three year performance period.

No exercise price is applicable for the awards.

As a result of the above transaction, the aggregate number of Shares held beneficially by the Executive Director (across all accounts) is as follows:

Director

Resulting aggregate number of Shares held beneficially (across all accounts)

Total percentage holding following notification

David Mellors

491,769

0.08%

 

This notification is made pursuant to rule 3.1.4R of the FCA Disclosure Rules and Transparency Rules.

END

 

For further information:

 

Jon Messent, Company Secretary, QinetiQ Group plc

 

David Bishop, Investor Relations, QinetiQ Group plc

 

01252 392000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSAFIWFISELA
Date   Source Headline
30th May 202212:03 pmRNSNotification of Major Shareholding
23rd May 20227:00 amRNSConfirmation of Full Year Results
19th May 20227:00 amRNSPreliminary Results
18th May 20227:00 amRNSDirectorate Change
17th May 202211:24 amRNSHolding(s) in Company
16th May 20221:45 pmRNSHolding(s) in Company
10th May 202211:49 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSInvestor Seminar: Delivering our global ambition
26th Apr 20221:37 pmRNSHolding(s) in Company
21st Apr 20229:15 amRNSHolding(s) in Company
20th Apr 20227:00 amRNSFourth Quarter Trading Update
12th Apr 202212:45 pmRNSDirector/PDMR Shareholding
10th Mar 202211:27 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
2nd Feb 20228:42 amRNSHolding(s) in Company
24th Jan 202211:12 amRNSDirector/PDMR Shareholding
19th Jan 20221:43 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSThird Quarter Trading Update
17th Jan 20227:00 amRNSAppointment of President and CEO of QinetiQ US
11th Jan 202211:43 amRNSDirector/PDMR Shareholding
5th Jan 20225:05 pmRNSDirector/PDMR Shareholding
20th Dec 20219:21 amRNSDirector Declaration
10th Dec 202112:42 pmRNSDirector/PDMR Shareholding
6th Dec 202112:16 pmRNSHolding(s) in Company
18th Nov 202111:04 amRNSDirector/PDMR Shareholding
17th Nov 202110:54 amRNSDirector/PDMR Shareholding
16th Nov 202111:24 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSInterim Results
10th Nov 202112:12 pmRNSDirector/PDMR Shareholding
1st Nov 202111:43 amRNSBlock listing Interim Review
19th Oct 20219:16 amRNSHolding(s) in Company
14th Oct 20217:00 amRNSTrading Update
12th Oct 202110:43 amRNSDirector/PDMR Shareholding
10th Sep 20212:07 pmRNSDirector/PDMR Shareholding
31st Aug 20212:35 pmRNSDirector/PDMR Shareholding
11th Aug 20219:07 amRNSDirector/PDMR Shareholding
27th Jul 202110:46 amRNSDirectorate Change
26th Jul 20214:33 pmRNSDirector/PDMR Shareholding
21st Jul 202110:55 amRNSResult of AGM
21st Jul 20217:00 amRNSFirst Quarter Trading Update
14th Jul 20218:47 amRNSChange of AGM venue
13th Jul 20219:52 amRNSHolding(s) in Company
12th Jul 202111:12 amRNSDirector/PDMR Shareholding
2nd Jul 20217:00 amRNSChief Financial Officer succession
29th Jun 20213:49 pmRNSDirector/PDMR Shareholding
15th Jun 202110:55 amRNSAnnual Financial Report
10th Jun 202111:15 amRNSDirector/PDMR Shareholding
9th Jun 20215:01 pmRNSDirector/PDMR Shareholding
1st Jun 20219:34 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.